Search filters

List of works by Itamar Raz

A polygenic risk score predicts atrial fibrillation in cardiovascular disease

scientific article published in 2022

Adolescent Hypertension and Risk for Early-Onset Type 2 Diabetes: A Nationwide Study of 1.9 Million Israeli Adolescents

scientific article published on 04 November 2020

Adolescent Obesity and Early-Onset Type 2 Diabetes

scientific article published on 22 April 2020

Calculating individualized glycaemic targets using an algorithm based on expert worldwide diabetologists: implications in real-life clinical practice

scientific article published on 22 December 2017

Cardiorenal Outcomes with Dapagliflozin by Baseline Glucose Lowering Agents -Post-hoc Analyses from DECLARE-TIMI 58

scientific article published on 26 August 2020

Cardiovascular Outcomes According to Urinary Albumin and Kidney Disease in Patients With Type 2 Diabetes at High Cardiovascular Risk: Observations From the SAVOR-TIMI 53 Trial.

scientific article

Cardiovascular Outcomes of Patients in SAVOR-TIMI 53 by Baseline Hemoglobin A1c.

scientific article published on 30 October 2015

Cardiovascular and renal benefits of dapagliflozin in patients with short and long-standing type 2 diabetes: Analysis from the DECLARE-TIMI 58 trial

scientific article published on 23 February 2020

Cardiovascular and renal outcomes by baseline albuminuria status and renal function - results from the LEADER randomized trial

scientific article published on 03 July 2020

Childhood Pancreatitis and Risk for Incident Diabetes in Adulthood

scientific article published on 06 November 2019

Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease

scientific article published on 13 November 2020

Declare-Timi 58: Participants' Baseline Characteristics

scientific article published on 11 January 2018

Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes

scientific article published on 29 April 2019

Effect of Saxagliptin on Renal Outcomes in the SAVOR-TIMI 53 Trial

scientific article published on 17 October 2016

Efficacy and Safety of Dapagliflozin in the Elderly: Analysis From the DECLARE-TIMI 58 Study

scientific article published on 16 December 2019

Efficacy and safety of saxagliptin in older participants in the SAVOR-TIMI 53 trial

scientific article

Five years to the Israeli National Diabetes Program - are we on the right track?

scientific article published on 11 November 2020

Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial

scientific article published on 04 September 2014

Hemoglobin A1C is a Predictor of COVID-19 Severity in Patients with Diabetes

scientific article published on 27 August 2020

NAFLD in type 2 diabetes mellitus - still many challenging questions

scientific article published on 17 July 2020

Patient clusters based on HbA1c trajectories: A step toward individualized medicine in type 2 diabetes

scientific article published in PLoS ONE

Positioning sulfonylureas in a modern treatment algorithm for patients with type 2 diabetes: expert opinion from a European Consensus Panel

scientific article published on 01 June 2020

Prediction of progression from pre-diabetes to diabetes: Development and validation of a machine learning model

scientific article published on 14 January 2020

Prognostic Implications of Biomarker Assessments in Patients With Type 2 Diabetes at High Cardiovascular Risk: A Secondary Analysis of a Randomized Clinical Trial

scientific article published on 28 September 2016

Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial

scientific article published on 23 September 2019

Response to Letter Regarding Article, "Heart Failure, Saxagliptin and Diabetes Mellitus: Observations From the SAVOR-TIMI 53 Randomized Trial".

scientific article published in August 2015

Risk Assessment in Patients With Diabetes With the TIMI Risk Score for Atherothrombotic Disease

scientific article published in December 2017

Safety of dapagliflozin in a broad population of patients with type 2 diabetes - analyses from the DECLARE - TIMI 58 study

scientific article published on 02 April 2020

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes and moderate or severe renal impairment: observations from the SAVOR-TIMI 53 Trial

scientific article published on 31 December 2014

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

scientific article

Tackling Obesity During the COVID-19 Pandemic

scientific article published on 14 August 2020

The Relationship between Inpatient Hyperglycemia and Mortality is Modified by Baseline Glycemic Status

scientific article published on 02 November 2020

The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study

scientific article published in November 2011

Validity of Diagnostic Codes and Estimation of Prevalence of Diabetic Foot Ulcers using a Large Electronic Medical Record Database

scientific article published on 20 November 2018